Non-invasive Transcutaneous Spinal Cord Stimulation Programming Recommendations for the Treatment of Upper Extremity Impairment in Tetraplegia.

Amplitude frequency motor threshold noninvasive spinal cord stimulation spinal cord injury transcutaneous spinal cord stimulation waveform

Journal

Neuromodulation : journal of the International Neuromodulation Society
ISSN: 1525-1403
Titre abrégé: Neuromodulation
Pays: United States
ID NLM: 9804159

Informations de publication

Date de publication:
02 Jul 2024
Historique:
received: 05 02 2024
revised: 30 04 2024
accepted: 18 05 2024
medline: 3 7 2024
pubmed: 3 7 2024
entrez: 3 7 2024
Statut: aheadofprint

Résumé

This study analyzes the stimulation parameters implemented during two successful trials that used non-invasive transcutaneous spinal cord stimulation (tSCS) to effectively improve upper extremity function after chronic spinal cord injury (SCI). It proposes a framework to guide stimulation programming decisions for the successful translation of these techniques into the clinic. Programming data from 60 participants who completed the Up-LIFT trial and from 17 participants who subsequently completed the LIFT Home trial were analyzed. All observations of stimulation amplitudes, frequencies, waveforms, and electrode configurations were examined. The incidence of adverse events and relatedness to stimulation parameters is reported. A comparison of parameter usage across the American Spinal Injury Association Impairment Scale (AIS) subgroups was conducted to evaluate stimulation strategies across participants with varying degrees of sensorimotor preservation. Active (cathodal) electrodes were typically placed between the C3/C4 and C6/C7 spinous processes. Most sessions featured return (anodal) electrodes positioned bilaterally over the anterior superior iliac spine, although clavicular placement was frequently used by 12 participants. Stimulation was delivered with a 10-kHz carrier frequency and typically a 30-Hz burst frequency. Biphasic waveforms were used in 83% of sessions. Average stimulation amplitudes were higher for biphasic waveforms. The AIS B subgroup required significantly higher amplitudes than did the AIS C and D subgroups. Device-related adverse events were infrequent, and not correlated with specific waveforms or amplitudes. Within the home setting, participants maintained their current amplitudes within 1% of the preset values. The suggested stimulation programming framework dictates the following hierarchical order of parameter adjustments: current amplitude, waveform type, active/return electrode positioning, and burst frequency, guided by clinical observations as required. This analysis summarizes effective stimulation parameters from the trials and provides a decision-making framework for clinical implementation of tSCS for upper extremity functional restoration after SCI. The parameters are aligned with existing literature and proved safe and well tolerated by participants.

Identifiants

pubmed: 38958629
pii: S1094-7159(24)00111-9
doi: 10.1016/j.neurom.2024.05.005
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of Interest Kristen Gelenitis, Jared Pradarelli, Jenny Suggitt, Amanda Turner, and Markus Rieger are employees of ONWARD Medical. Andrea Santamaria, Jessica M D’Amico, Edelle Field-Fote, and Chet Moritz are paid consultants of ONWARD Medical. The remaining authors reported no conflict of interest.

Auteurs

Kristen Gelenitis (K)

ONWARD Medical, Lausanne, Switzerland.

Andrea Santamaria (A)

ONWARD Medical, Lausanne, Switzerland.

Jared Pradarelli (J)

ONWARD Medical, Lausanne, Switzerland.

Markus Rieger (M)

ONWARD Medical, Lausanne, Switzerland.

Fatma Inanici (F)

Departments of Rehabilitation Medicine, Electrical & Computer Engineering, Center for Neurotechnology, University of Washington. Seattle, WA, USA.

Candace Tefertiller (C)

Craig Hospital. Englewood, CO, USA.

Edelle Field-Fote (E)

Shepherd Center, Crawford Research Institute, Emory University School of Medicine, Department of Rehabilitation Medicine, School of Biological Sciences, Georgia Institute of Technology, Atlanta, GA, USA.

James Guest (J)

Neurological Surgery and the Miami Project to Cure Paralysis, Miller School of Medicine, University of Miami, Miami, FL, USA.

Jenny Suggitt (J)

ONWARD Medical, Lausanne, Switzerland.

Amanda Turner (A)

ONWARD Medical, Lausanne, Switzerland.

Jessica M D'Amico (JM)

ONWARD Medical, Lausanne, Switzerland; Glenrose Rehabilitation Hospital, Alberta Health Services. Edmonton, Canada; Department of Medicine, University of Alberta. Edmonton, Canada.

Chet Moritz (C)

Departments of Rehabilitation Medicine, Electrical & Computer Engineering, Center for Neurotechnology, University of Washington. Seattle, WA, USA; Department of Physiology & Biophysics, University of Washington. Seattle, WA, USA. Electronic address: ctmoritz@uw.edu.

Classifications MeSH